Nanosafety is a critical facet of ensuring the responsible development and application of nanotechnology-based drugs and products. With the increasing integration of nanomaterials in pharmaceutical formulations, concerns about potential adverse effects on human health and the environment have grown. Rigorous safety assessments are essential to address these concerns, encompassing aspects such as toxicity, biodistribution, and biocompatibility of nanomaterials. Comprehensive studies are conducted to understand the interactions between nanoparticles and biological systems, evaluating their potential to induce cellular damage or trigger immune responses.
Regulatory bodies and industry stakeholders collaborate to establish guidelines that govern the safe use of nanomaterials in pharmaceuticals, aiming to mitigate risks and enhance patient safety. Moreover, ongoing research endeavors focus on developing innovative nanosafety assessment methods and predictive models to streamline the evaluation process. As the pharmaceutical landscape continues to advance with nanotechnology, prioritizing nanosafety remains paramount to harness the full therapeutic potential of these novel formulations while safeguarding public health.
Submit your abstract Today
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India